Skip to main content
Log in

Thyroid Nodules in Type 2 Diabetes Mellitus

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

The present analysis aims to investigate the prevalence of thyroid nodules in type 2 diabetes mellitus (T2DM) population. We searched PubMed, EMBASE, and Web of Science from inception to the March 1, 2018. The studies were selected to estimate the prevalence of thyroid nodules in T2DM subjects and to compare the prevalence of thyroid nodules in different glucose tolerance status. The random effects model was used, and the outcome was presented as a pooled prevalence proportion with 95% confidence interval (95% CI) or a summary odds ratio (OR) with 95% CI. In the end, 9 studies met the inclusion criteria and were included in the analysis. The pooled prevalence of thyroid nodules was 60% (95% CI: 0.52, 0.68) for T2DM 2 diabetes patients, 50% (95% CI: 0.48, 0.51) for pre-diabetes, and 43% (95% CI: 0.34, 0.52) for normal glucose tolerance population. Compared with patients without diabetes, diabetes subjects are more likely to develop thyroid nodules, adjusted OR for thyroid nodule was 1.78 (95% CI: 1.25, 2.55). Insulin resistance might be involved in thyroid nodule development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res, 2011,2011:439463

    Article  Google Scholar 

  2. Peppa M, Koliaki C, Nikolopoulos P, et al. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol, 2010,2010:527850

    Article  Google Scholar 

  3. Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf), 2011,75(1):1–9

    Article  CAS  Google Scholar 

  4. Han C, He X, Xia X, et al. Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLoS One, 2015,10(8):e0135233

    Article  Google Scholar 

  5. Gierach M, Gierach J, Junik R. Insulin resistance and thyroid disorders. Endokrynol Pol, 2014,65(1):70–76

    Article  Google Scholar 

  6. Han C, Xia X, Liu A, et al. Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism. Biomed Res Int, 2016,2016:5090852

    PubMed  PubMed Central  Google Scholar 

  7. Agbaht K, Erdogan MF, Emral R, et al. Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism. Endocrine, 2014,45(1):106–113

    Article  CAS  Google Scholar 

  8. Miyauchi S, Matsuura B, Ueda T, et al. Interleukin-18 induces insulin resistance in the hyperthyroid state. Endocr J, 2013,60(4):449–455

    CAS  PubMed  Google Scholar 

  9. Wang C. The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. J Diabetes Res, 2013,2013:390534

    PubMed  PubMed Central  Google Scholar 

  10. Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract, 2010,64(8):1130–1139

    Article  CAS  Google Scholar 

  11. Rai S, Kumar JA, KP, et al. Thyroid function in type 2 diabetes mellitus and in diabetic nephropathy. J Clin Diagn Res, 2013,7(8):1583–1585

    PubMed  PubMed Central  Google Scholar 

  12. Somwaru LL, Arnold AM, Joshi N, et al. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab, 2009,94(4):1342–1345

    Article  CAS  Google Scholar 

  13. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am, 2007,36(3):707–735, vi

    Article  CAS  Google Scholar 

  14. Ayturk S, Gursoy A, Kut A, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol, 2009,161(4):599–605

    Article  CAS  Google Scholar 

  15. Rezzonico J, Rezzonico M, Pusiol E, et al. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid, 2008,18(4):461–464

    Article  CAS  Google Scholar 

  16. Junik R, Kozinski M, Debska- Kozinska K. Thyroid ultrasound in diabetic patients without overt thyroid disease. Acta Radiologica, 2006,47(7):687–691

    Article  CAS  Google Scholar 

  17. Anil C, Akkurt A, Ayturk S, et al. Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism, 2013,62(7):970–975

    Article  CAS  Google Scholar 

  18. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. fJAMA, 2000,283(15):2008–2012

    CAS  Google Scholar 

  19. Liu Y, Liu J, Zhang T, et al. Type 2 diabetes mellitus associated with thyroid nodules: a longitudinal health check-up cohort study. J Shandong Univ (Chinese), 2015,53(8):83–86

    Google Scholar 

  20. Huang XQ, Zhang HA, Huang Q. Correlation analysis between type 2 diabetes mellitus and thyroid nodules in elderly patients. Dier Junyi Daxue Xuebao (Chinese), 2015,36(2):221–225

    Google Scholar 

  21. Ittermann T, Markus MR, Schipf S, et al. Metformin inhibits goitrogenous effects of type 2 diabetes. Eur J Endocrinol, 2013,169(1):9–15

    Article  CAS  Google Scholar 

  22. Guo H, Sun M, He W, et al. The prevalence of thyroid nodules and its relationship with metabolic parameters in a Chinese community-based population aged over 40 years. Endocrine, 2014,45(2):230–235

    Article  CAS  Google Scholar 

  23. Tu W, Zhang G, Yu S, et al. Observations on factors that influence thyroid nodules in diabetic and non-diabetic patients in the Zhejiang province of China. Int J Clin Exp Med, 2015,8(10):19332–19338

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Zheng L, Yan W, Kong Y, et al. An epidemiological study of risk factors of thyroid nodule and goiter in Chinese women. Int J Clin Exp Med, 2015,8(7):11379–11387

    PubMed  PubMed Central  Google Scholar 

  25. Tao YH, Bi FF, Liu GL. Analysis of the prevalence rate and risk factors of thyroid nodules in Tangshan City. Occupation Health (Chinese), 2014,30(23):3415–3417

    Google Scholar 

  26. Rezzonico JN, Rezzonico M, Pusiol E, et al. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord, 2009,7(4):375–380

    Article  CAS  Google Scholar 

  27. Godsland IF. Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond), 2009,118(5):315–332

    Google Scholar 

  28. Jalving M, Gietema JA, Lefrandt JD, et al. Metformin: taking away the candy for cancer? Eur J Cancer, 2010,46(13):2369–2380

    Article  CAS  Google Scholar 

  29. Silberschmidt D, Krawiec L, Bocanera LV, et al. Effect of the interaction of TSH and insulin on the stimulation of 2-deoxyglucose uptake in FRTL-5 cells. J Endocrinol Invest, 1999,22(7):499–502

    Article  CAS  Google Scholar 

  30. Blancquaert S, Wang L, Paternot S, et al. cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4. Mol Endocrinol, 2010,24(7):1453–1468

    Article  CAS  Google Scholar 

  31. Santisteban P, Acebron A, Polycarpou-Schwarz M, et al. Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol Endocrinol, 1992,6(8):1310–1317

    CAS  PubMed  Google Scholar 

  32. Rapoport B, Chazenbalk GD, Jaume JC, et al. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev, 1998,19(6):673–716

    CAS  PubMed  Google Scholar 

  33. Kimura T, Van Keymeulen A, Golstein J, et al. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev, 2001,22(5):631–656

    Article  CAS  Google Scholar 

  34. Rapp K, Schroeder J, Klenk J, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia, 2006,49(5):945–952

    Article  CAS  Google Scholar 

  35. Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med, 2006,166(17):1871–1877

    Article  Google Scholar 

  36. Blanc E, Ponce C, Brodschi D, et al. Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome. Metab Syndr Relat Disord, 2015,13(5):221–226

    Article  CAS  Google Scholar 

  37. Santos MC, Louzada RA, Souza EC, et al. Diabetes mellitus increases reactive oxygen species production in the thyroid of male rats. Endocrinology, 2013,154(3):1361–1372

    Article  CAS  Google Scholar 

  38. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract, 2014,103(2):137–149

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Qing Su or Xia Wang.

Additional information

This project was supported by the National Natural Science Foundation of China (No. 81300642).

Conflict of Interest Statement

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Hm., Feng, Qw., Niu, Yx. et al. Thyroid Nodules in Type 2 Diabetes Mellitus. CURR MED SCI 39, 576–581 (2019). https://doi.org/10.1007/s11596-019-2076-5

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-019-2076-5

Key words

Navigation